生物制造，国投再出手！瞄准这一百亿市场！

TL;DR - Shanghai-based synthetic biology firm NewPro Bioworks raised a tens-of-millions-RMB Pre-A round led by Shanghai Guotou Xiandao and Aochuang Xiandao, and secured US FDA Self-GRAS status for its precision-fermented lactoferrin — a bid for the ~$6.5B functional food protein market.

• Funding targets three uses: China novel-food-ingredient regulatory filing for lactoferrin, overseas commercialization on the back of FDA Self-GRAS, and scale-up of functional protein production capacity.
• Core tech stack: a proprietary industrial chassis engineering system (FlexBase™) and a precision fermentation process (NeuroBrew™); founded 2024.
• AI angle: thousands of bench-scale fermentation batches were used to build a domain-specific data model now driving intelligent fermentation control and process optimization at pilot and production scale.
• Market/pipeline: Grand View Research puts 2023 functional food protein at $6.5B growing 5.3% CAGR; pipeline extends beyond lactoferrin to osteopontin and ovalbumin.